Aarti Drugs Limited

Web: aartidrugs.com NSE: AARTIDRUGS BSE: 524348 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

433 7(2%)

Volume

4L as on 23, Jun

Open

424

High

428

Low

421

426

VWAP

378

52 Week High

535

52 Week Low

319

Viand Research Rating

Quality Score

16/100

Growth Score

29/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

3,951

No. of Shares

9.13

P/E

33.48

P/B

3.61

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

10.79

ROCE

Profit Growth

Listing Date

19-Sep-03

Promoter Holding

54.43%

FII Holding

1.52%

DII Holding

10.29%

Price Chart

Price Performance

1 Week1%

1 Month4%

3 Months15%

6 Months5%

1 Year5%

YTD5%

Moving Average

5 Day SMA372

10 Day SMA372

20 Day SMA376

30 Day SMA376

50 Day SMA376

61 Day SMA370

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	388	379	383	390
Resistance 2	383	378	380	384
Resistance 1	380	377	378	382
Pivot Point	375	376	375	376
Support 1	371	376	372	373
Support 2	367	375	370	367
Support 3	363	374	367	365

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(-0.61) 54.43%	(0.01) 55.03%	(0.31) 55.03%	(-0.51) 54.72%	(-0.31) 55.23%	(0.11) 55.48%	(-0.31) 55.38%	(0.01) 55.64%	(-1.51) 55.67%	(-0.31) 57.13%	(-1.11) 57.47%	(-0.11) 58.57%	(-0.91) 58.70%	(-0.11) 59.57%	(-0.11) 59.66%	(-0.21) 59.77%	(0.11) 59.98%	(-0.21) 59.83%	(-0.11) 59.99%	(0.01) 60.12%
FIIs	(-0.11) 1.52%	(-0.61) 1.57%	(-0.51) 2.15%	(0.41) 2.68%	(0.01) 2.26%	(0.01) 2.25%	(-0.21) 2.28%	(-0.51) 2.50%	(0.41) 2.95%	(0.51) 2.56%	(-0.21) 2.10%	(0.41) 2.33%	(0.01) 1.97%	(0.01) 1.94%	(0.01) 1.90%	(-0.11) 1.94%	(0.01) 2.07%	(0.01) 2.07%	(-0.21) 2.03%	(0.01) 2.21%
DIIs	(0.11) 10.29%	(0.11) 10.22%	(0.21) 10.12%	(0.01) 9.90%	(0.21) 9.94%	(0.91) 9.70%	(0.91) 8.77%	(0.51) 7.83%	(1.41) 7.35%	(0.71) 5.99%	(-0.11) 5.26%	(0.61) 5.32%	(0.61) 4.72%	(0.21) 4.09%	(0.71) 3.90%	(0.41) 3.16%	(0.11) 2.76%	(0.41) 2.69%	(0.21) 2.28%	(0.01) 2.12%
Public	33.76%	33.19%	32.71%	32.70%	32.58%	32.57%	33.58%	34.01%	34.01%	34.30%	35.16%	33.78%	34.63%	34.39%	34.53%	35.11%	35.19%	35.41%	35.71%	35.55%
No. of Shareholders	143,476	144,946	148,363	152,252	160,260	169,761	176,006	190,281	150,218	157,547	170,414	167,446	162,409	169,090	173,283	180,303	186,674	189,607	195,469	183,344

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	703	720	602	653	591	677	557	598	555	620	606	642	661	742	664	688	622	694	635	580	580
Sales Growth % (YoY)	19%	6.4%	8.1%	9.1%	6.3%	9.2%	-8.1%	-6.7%	-16%	-16.5%	-8.7%	-6.7%	6.3%	6.9%	4.6%	18.6%	7.2%	38.4%	19.7%	0.3%	6.5%
Sales Growth % (QoQ)	-2.4%	19.6%	-7.8%	10.5%	-12.7%	21.5%	-6.9%	7.7%	-10.5%	2.3%	-5.6%	-2.9%	-10.9%	11.7%	-3.5%	10.6%	-10.4%	9.3%	9.5%	-	-
Expenses	605	624	547	569	516	583	495	531	490	534	536	565	577	649	593	613	555	608	545	506	500
Operating Profit	98	96	55	84	74	93	62	67	65	86	70	76	84	94	71	74	67	86	90	74	80
OPM %	14	13	9	13	13	14	11	11	12	14	12	12	13	13	11	11	11	12	14	13	14
Other Income	-1	1	1	0	0	2	12	1	1	1	2	1	1	1	1	0	0	3	7	0	2
Interest	9	8	9	8	9	9	9	9	9	9	8	8	9	9	9	8	7	6	5	5	4
Depreciation	18	18	18	16	15	15	14	14	13	14	13	13	13	12	13	13	13	13	13	12	12
Profit before tax	69	70	29	60	51	71	51	46	44	64	52	56	64	73	50	53	48	70	79	56	65
Tax %	28	21	-40	25	-6	12	27	24	24	26	29	30	24	23	26	27	28	22	26	24	25
Net Profit	50	55	41	45	54	63	37	35	33	47	37	40	48	56	37	39	35	55	58	43	49
Net Profit Growth % (QoQ)	-9.1%	34.1%	-8.9%	-16.7%	-14.3%	70.3%	5.7%	6.1%	-29.8%	27%	-7.5%	-16.7%	-14.3%	51.4%	-5.1%	11.4%	-36.4%	-5.2%	34.9%	-12.2%	-
Net Profit Growth % (YoY)	-7.4%	-12.7%	10.8%	28.6%	63.6%	34%	-	-12.5%	-31.2%	-16.1%	-	2.6%	37.1%	1.8%	-36.2%	-9.3%	-28.6%	-	-	-	-
TTM Net Profit	191	195	203	199	189	168	152	152	157	172	181	181	180	167	166	187	191	205	150	92	0
EPS in Rs	5.5	6.05	4.44	4.96	5.91	6.89	4.06	3.84	3.62	5.15	3.99	4.31	5.17	6.06	3.96	4.18	3.76	5.98	6.29	4.6	5.27

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2011	Mar 2010
Sales	2565	2387	2529	2716	2489	2155	1806	1561	1244	1195	1140	1097	501	479
Sales Growth %	7.5%	-5.6%	-6.9%	9.1%	15.5%	19.3%	15.7%	25.5%	4%	4.8%	3.9%	-	4.7%	25.2%
Expenses	2256	2097	2208	2407	2156	1714	1541	1350	1042	1005	960	925	432	396
Operating Profit	309	290	321	309	333	440	266	211	202	190	180	172	69	83
OPM %	12	12	13	11	13	20	15	14	16	16	16	16	14	17
Other Income	2	16	4	2	11	5	6	6	1	4	0	1	0	0
Interest	34	39	38	37	24	26	37	44	38	40	48	42	17	19
Depreciation	67	56	51	50	50	50	49	43	40	38	37	31	19	17
Profit before tax	211	212	236	224	270	369	185	131	125	116	95	100	33	47
Tax %	8	21	27	26	24	24	24	32	34	29	28	23	29	40
Net Profit	195	168	172	166	205	280	141	90	82	82	69	77	24	29
Net Profit Growth %	16.1%	-2.3%	3.6%	-19%	-26.8%	98.6%	56.7%	9.8%	-	18.8%	-10.4%	220.8%	-17.2%	-
EPS in Rs	21.36	18.42	18.65	17.96	22.14	30.09	15.17	9.52	8.73	8.57	7.09	7.97	2.46	2.92
Dividend Payout %	9	5	5	6	5	8	3	3	3	3	24	41	25	21

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2011	Mar 2010
Cash from Operating Activity	254	245	359	133	70	155	251	143	70	175	133	105	21	59
Cash from Investing Activity	-173	-165	-224	-164	-150	-72	-33	-62	-74	-107	-99	-107	-76	-30
Cash from Financing Activity	-77	-82	-136	17	92	-81	-215	-80	4	-68	-33	1	53	-24
Net Cash Flow	3	-2	-1	-14	13	2	2	1	0	0	1	-1	-3	5

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2011	Mar 2010
Equity Capital	91	91	91	91	92	93	93	93	23	24	24	24	24	24	12	12
Reserves	1458	1377	1278	1186	1190	1100	944	820	629	520	432	376	333	284	151	134
Borrowings	577	573	615	590	564	609	543	351	389	507	546	480	483	448	267	189
Other Liabilities	690	570	591	562	587	620	629	502	535	405	388	311	261	248	93	84
Total Liabilities	2815	2612	2575	2430	2432	2421	2208	1766	1576	1455	1389	1191	1102	1004	523	419
Fixed Assets	1086	1078	866	838	811	676	690	665	644	625	602	581	493	448	248	208
CWIP	214	179	330	299	261	210	77	19	12	33	28	14	34	16	10	3
Investments	27	23	22	20	20	19	19	17	13	12	11	12	5	5	5	2
Other Assets	1488	1332	1356	1273	1340	1516	1422	1064	907	785	748	584	570	534	260	206
Total Assets	2815	2612	2575	2430	2432	2421	2208	1766	1576	1455	1389	1191	1102	1004	523	419

Delivery

Delivery Data: AARTIDRUGS

#	Date	369 23% 454	Value (Cr)	Q/T 31	Del 47	Del 10
1	4-Sep	432	11	29	46	5
2	3-Sep	426	16	36	46	8
3	2-Sep	418	7	27	55	4
4	1-Sep	427	11	29	37	4
5	31-Aug	412	2	21	55	1
6	28-Aug	419	3	18	57	1
7	27-Aug	418	3	22	48	2
8	26-Aug	418	3	25	52	1
9	25-Aug	422	5	30	50	2
10	24-Aug	421	9	33	42	4
11	21-Aug	417	7	29	48	3
12	20-Aug	415	6	23	42	2
13	19-Aug	408	5	26	49	3
14	18-Aug	413	4	24	60	2
15	17-Aug	411	6	24	53	3
16	14-Aug	416	7	27	59	4
17	13-Aug	428	6	21	44	3
18	12-Aug	432	16	28	44	7
19	11-Aug	439	61	44	31	19
20	10-Aug	423	9	32	62	6
21	7-Aug	416	4	24	50	2
22	6-Aug	411	4	29	55	2
23	5-Aug	412	5	23	54	2
24	4-Aug	414	7	37	52	4
25	3-Aug	407	16	31	43	7
26	31-Jul	423	8	33	54	4
27	30-Jul	413	7	34	44	3
28	29-Jul	411	5	33	51	3
29	28-Jul	408	3	29	50	1
30	27-Jul	411	3	25	55	2
31	24-Jul	404	3	27	53	2
32	23-Jul	410	3	26	46	1
33	22-Jul	412	13	30	43	6
34	21-Jul	427	6	31	58	4
35	20-Jul	418	8	29	37	3
36	17-Jul	422	9	32	47	4
37	16-Jul	420	12	31	46	6
38	15-Jul	422	28	34	45	12
39	14-Jul	406	23	35	44	10
40	13-Jul	396	4	29	43	2
41	10-Jul	397	3	24	50	2
42	9-Jul	395	12	33	44	6
43	8-Jul	387	11	33	50	5
44	7-Jul	389	8	30	48	4
45	6-Jul	380	3	27	63	2
46	3-Jul	387	7	33	47	3
47	2-Jul	384	6	41	64	4
48	1-Jul	376	5	30	48	2
49	30-Jun	378	18	45	32	6
50	29-Jun	373	3	31	47	2

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	3,951c	21c	0.52
03-Sep	3,971c	160c	4.19
01-Sep	3,811c	26c	0.69
31-Aug	3,785c	59c	1.54
26-Aug	3,845c	8c	0.20
25-Aug	3,837c	24c	0.61
24-Aug	3,861c	94c	2.50
21-Aug	3,767c	37c	1.00
19-Aug	3,729c	40c	1.07
18-Aug	3,770c	20c	0.54
17-Aug	3,749c	38c	1.01
14-Aug	3,788c	163c	4.12
13-Aug	3,951c	1c	0.03
12-Aug	3,952c	39c	0.97
11-Aug	3,991c	130c	3.37
10-Aug	3,861c	83c	2.20
06-Aug	3,778c	21c	0.56
05-Aug	3,757c	11c	0.29
04-Aug	3,768c	40c	1.07
03-Aug	3,728c	133c	3.44
31-Jul	3,861c	66c	1.73
30-Jul	3,795c	33c	0.87
29-Jul	3,762c	51c	1.38
28-Jul	3,711c	31c	0.83
27-Jul	3,742c	18c	0.49
24-Jul	3,724c	0	0

Stock Checklist

Price is above from 52 week high low average: 53%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 20 fund scheme(s) across 7 fund house(s) as of Aug26 · Total value ₹778 Cr · 4 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
DSP Mutual Fund	4	1.31%	+0.01%	612.1
ICICI Prudential Mutual Fund	2	1.16%	+0.10%	157.7
Motilal Oswal Mutual Fund	4	0.16%	-	7.9
Groww Mutual Fund	2	0.01%	-	0.1
Bandhan Mutual Fund	4	0.02%	-0.01%	0
Angel One Mutual Fund	2	0.00%	-	0
Mirae Asset Mutual Fund	2	0.00%	-	0

Aarti Drugs Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements